Research Article
Integrated Analysis Identifies an Immune-Based Prognostic Signature for the Mesenchymal Identity in Gastric Cancer
Table 1
Patients’ characteristics in public datasets.
| | Training cohort | Validation cohorts | GSE15459 () | GSE13861 () | GSE84437 () | GSE62254 () | GSE26901 () | GSE29272 () |
| Age (years) | 64 (23-92) | 61 (32-83) | 60 (27-86) | 62 (24-86) | 56 (28-74) | 56 (23-73) | Gender | | | | | | | Female | 67 (35%) | 19 (29%) | 137 (32%) | 101 (34%) | 37 (38%) | 31 (23%) | Male | 125 (65%) | 46 (71%) | 296 (68%) | 199 (66%) | 60 (62%) | 103 (77%) | Histology | | | | | | | Diffuse | 75 (39%) | 30 (46%) | | 135 (45%) | 10 (10%) | | Indeterminate | | | | 2 (1%) | | | Intestinal | 99 (52%) | 19 (29%) | | 146 (49%) | 71 (73%) | | Mixed | 18 (9%) | 12 (18%) | | 17 (6%) | 5 (5%) | | Unknown | | 4 (6%) | | | 11 (11%) | | Site | | | | | | | Antrum | | 26 (40%) | | 152 (51%) | 51 (53%) | | Body | | 31 (48%) | | 110 (37%) | 30 (31%) | | Cardia | | 4 (6%) | | 32 (11%) | | | Entire | | 1 (2%) | | 3 (1%) | 4 (4%) | | Fundus | | 1 (2%) | | | 12 (12%) | | Unknown | | 2 (3%) | | | | | Stage | | | | | | | I | 31 (16%) | 12 (18%) | | 31 (10%) | 33 (34%) | 5 (4%) | II | 29 (15%) | 12 (18%) | | 97 (32%) | 17 (18%) | 5 (4%) | III | 72 (38%) | 25 (38%) | | 95 (32%) | 32 (33%) | 115 (86%) | IV | 60 (31%) | 16 (25%) | | 77 (26%) | 15 (15%) | 9 (7%) |
|
|